CACNA1A and leukemia: These observations align with other made by large international leukemia consortia, including the European Group for the Immunological characterization of leukemias (EGIL) and the Current National Comprehensive Cancer Network (NCCN), which offer immunophenotypic frameworks (e.g., BI–BIII, Pro-B to Mature B-ALL) based on immunophenotype data (46–48).